M
MBX
MBX Biosciences Inc
50.29
+1.79+3.69%After Hours: 50.29 0.00 0.00%16:10 10/26 EDT
OPEN/PREV CLOSE48.93/48.50
TODAY RANGE47.93-50.81
VOL653.05K
MARKET CAP2.42B
52 WEEK RANGE13.22-72.64
AVG VOL (3M)516.79K
% TURNOVER1.22%
TURNOVER--
P/E (TTM)-20.9071
% RANGE5.94%
EPS(TTM)-2.4054
P/E(FORWARD)-16.1147
P/B5.89
BVPS8.54
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.86B
SHARES OUTSTANDING48.16M
NEXT EARNINGS11/04-11/09
FREE FLOAT37.05M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·3h ago
Oppenheimer's top 50 small- and mid-cap Buy list
TipRanks·4d ago
MBX Biosciences Expands Board, Appoints New Director
Simply Wall St·10/17 10:29
Learn Why The Bull Case For MBX Biosciences Stock Could Change Following Early Obesity Data
TipRanks·10/13 08:56
Barclays Keeps Their Buy Rating on MBX Biosciences, Inc. (MBX)
Dow Jones·10/12 11:29
MBX Biosciences Is Maintained at Buy by Stifel
TipRanks·10/12 11:15
MBX Biosciences price target raised to $84 from $70 at Stifel
Simply Wall St·10/09 09:43
Is MBX Biosciences (MBX) Undervalued After Its Recent Pullback?
Dow Jones·10/02 13:15
MBX Biosciences Is Maintained at Buy by Guggenheim
Dow Jones·10/02 13:15
MBX Biosciences Price Target Raised to $150.00/Share From $88.00 by Guggenheim
Benzinga·10/02 13:05
Guggenheim Maintains Buy on MBX Biosciences, Raises Price Target to $150
TipRanks·10/02 10:50
MBX Biosciences price target raised to $150 from $88 at Guggenheim
Seeking Alpha·09/23 19:51
MBX Biosciences: I Should Never Have Downgraded To Hold (Rating Upgrade)
Same Industry
Name/Symbol
Change%
Price